Literature DB >> 7594672

The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland.

M T Kauppinen1, E Herva, P Kujala, M Leinonen, P Saikku, H Syrjälä.   

Abstract

The etiology of community-acquired pneumonia during a Chlamydia pneumoniae epidemic was studied among 125 hospitalized patients. Etiologic investigations included blood and sputum cultures, pneumococcal antigen detection, and serologic investigations for common respiratory viruses and for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumococcal antigen detection, and serologic investigations for common and for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, and Chlamydia species. A specific microbial agent was identified in 110 patients (88%). Some 48% of the patients had mixed infections. S. pneumoniae was the most common pathogen (55%), followed by C. pneumoniae (43%). C. pneumoniae was found both as a single etiologic agent and as a mixed infection, most often with S. pneumoniae. In conclusion, S. pneumoniae is the most common cause of community-acquired pneumonia, even during a C. pneumoniae epidemic. The organism, alone or with other pathogens (especially S. pneumoniae), may cause community-acquired pneumonia that requires hospital treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594672     DOI: 10.1093/infdis/172.5.1330

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.

Authors:  J A Brandenburg; T J Marrie; C M Coley; D E Singer; D S Obrosky; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

Review 2.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

3.  Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Authors:  K Loens; T Beck; H Goossens; D Ursi; M Overdijk; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Can J Infect Dis       Date:  2000-09

5.  Investigation of a Chlamydia pneumoniae outbreak in a Federal correctional facility in Texas.

Authors:  Laura Conklin; Jennifer Adjemian; Jennifer Loo; Sema Mandal; Carol Davis; Sharyn Parks; Tina Parsons; Brian McDonough; Jorge Partida; Kathleen Thurman; Maureen H Diaz; Alvaro Benitez; Tracy Pondo; Cynthia G Whitney; Jonas M Winchell; Newton Kendig; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2013-05-30       Impact factor: 9.079

6.  Validation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.

Authors:  J A Scott; A J Hall; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

7.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

8.  Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.

Authors:  W S Lim; J T Macfarlane; T C Boswell; T G Harrison; D Rose; M Leinonen; P Saikku
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

9.  Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome.

Authors:  F Gutiérrez; M Masiá; J C Rodríguez; C Mirete; B Soldán; S Padilla; I Hernández; G Royo; A Martin-Hidalgo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

Review 10.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.